The following is an excerpt.
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic AcidTherapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
View the original article here: Nanoparticles Boost Therapeutic Potential of siRNA Drugs
